Company Type Of Number Of Amount Investors; Placement Agents;
(Symbol) Financing Shares, Units Raised (M) Details (Date)
Or Warrants (M)
Abaxis Inc. (ABAX) Debt — $5.5 Transamerica Technology Finance is pro-
financing viding $5.5M in debt financing, consisting
of $3M for capital equipment and $2.5M in
working capital (9/9)
Celgene Corp. (CELG) Private ND $8.3 Celgene netted $8.3M from a private place-
placement ment with a single investor; the financing
"instrument" is convertible into stock at
$11.00 per share (9/17)
Celtrix Pharma- Interim — $2 As part of Celtrix's corporate restructuring,
ceuticals Inc. (CTRX) financing the company's existing investors committed
$2M in additional funding to extend its
cash resources into 4Q:99 (9/18)
Cypress Bioscience Private 2.2S $3.3 Cypress sold 2.18M shares of Series A pre-
Inc. (CYPB) placement ferred stock at $1.514 per share to current
shareholders and new institutional investors
in this placement; the preferred stock is con-
vertible on a 1:1 basis into common shares (9/16)
Hybridon Inc. Facility — $6.5 Hybridon terminated its lease on a facility
(OTC Bulletin consolidation owned by Charles River Building Limited
Board:HYBN) Partnership and is selling its interest in that
limited partnership; the company will get
$6.5M, including release of restricted cash,
in connection with these transactions (9/18)
ID Biomedical Corp. Private ND $4 ID Biomedical will sell $4M in Class A
(TSE:IDB; Canada) placement convertible preferred stock to a single
institutional investor; the preferred shares
carry a 6% annual dividend and can be con-
verted into common stock at market anytime
over 3 years; the investor will also get 0.3M
common stock purchase warrants, exercisable
over 2 years at a premium to market (9/14)
Xenova Group plc Rights 9.6U $18 Xenova sold 9.55M units at $1.88 each to
(XNVAY; U.K.) offering investors; 1.2M units were bought by
and private qualifying shareholders and the remainder
placement by new institutional and other investors;
each unit consists of 2 common shares and
1 warrant, which can be exercised at $1.20
until 12/31/99; Greig Middleton & Co. Ltd.
acted as the placement agent (prices con-
verted at a rate of £0.585/US$1) (9/29)
TOTAL: $47.6M
NOTES:
ND = Not disclosed, reported and/or available; S = Shares; U = Units; TSE = Toronto Stock Exchange; W = Warrants
The financings in this chart include loans, bridge financings and other interim measures as well as sales of business units, debt offerings, rights offerings, exercises of warrants, institutional offerings of registered stock and standard private placements.